Quantcast
Last updated on April 16, 2014 at 6:17 EDT

PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention

June 22, 2012

PRINCETON, N.J., June 22, 2012 /PRNewswire/ — PeriGen, Inc., an innovative, national provider of fetal surveillance systems, will introduce its newest and most advanced electronic fetal monitoring system, PeriCALM® Plus(TM), at the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) 2012 Annual Convention, being held June 23-28, 2012 in National Harbor, Maryland.

(Logo: http://photos.prnewswire.com/prnh/20110512/PH01144LOGO )

The PeriCALM® Plus(TM) suite is the only fetal surveillance system available today that provides automated visual cues that enable clinicians to easily and quickly spot clinically significant trends. This feature, known as PeriGen Visual Cueing(TM), provides an instant view of mothers’ and babies’ current status and trends over time, helping clinicians to avoid errors, increase patient safety and reduce risk. Importantly, Visual Cueing in PeriCALM Plus is supplemented by real-time, advanced decision-making support based on expert analysis and established labor and delivery protocols.

“Nurses are a driving force behind patient safety initiatives, so we could not be more pleased to be introducing PeriCALM Plus to the AWHONN conference attendees first-hand,” said Matt Sappern, CEO of PeriGen. “Our goal is to support their efforts to improve perinatal outcomes for mothers and babies by creating innovative, intuitive technologies that directly impact the quality of care.”

All of PeriGen’s fetal monitoring systems include patented, pattern-recognition software, which offers an objective interpretation of fetal heart rate tracings that is comparable to the analyses of recognized clinical experts. PeriCALM Plus couples PeriGen’s traditional fetal monitoring suite (PeriCALM) with comprehensive nursing and physician documentation, as well as protocol-driven decision support.

“PeriCALM Plus represents the next generation of perinatal systems,” said Sappern. “Fortunately for mothers, babies and clinicians, the market is moving past the decades-old perinatal systems that simply record data to technologies that proactively alert health care professionals to potential problems, and provide protocols for the care management of those problems that help make labor and delivery safer. This is where PeriGen excels.”

PeriCALM Plus 3.16.0 is ONC-ATCB Certified as a modular EHR under the Hospital domain. For full certification details, please visit https://www.cchit.org/show-onc-cert?certid=a055000000LedEDAAZ.

“The market is enthusiastically embracing PeriCALM Plus as a comprehensive solution to increasing healthcare and regulatory demands,” said Mike Pritts, president and chief technology officer, PeriGen. “The system is currently being evaluated by several hospitals across the United States, and was recently selected by Wheeling Hospital in Wheeling, West Virginia, an institution that manages more than 1,000 births annually.”

AWHONN attendees are invited to stop by the PeriGen booth (#200) to see PeriCALM Plus in action and meet the team of clinical experts behind PeriGen’s advanced fetal surveillance systems.

About PeriGen, Inc.

PeriGen is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. PeriGen’s customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.

PeriGen’s unique fetal surveillance products provide dynamic visual cues that direct clinicians to the most essential patient information displayed on the screen. Unlike legacy fetal monitoring devices and software from non-specialist companies, PeriGen Visual Cueing(TM) provides an instant view of the mother’s and baby’s current status and trends over time to avoid errors, increasing patient safety and reducing risk for clinicians and hospitals. For more information, please visit us at www.PeriGen.com.

Sandra Taylor, Ph.D.
Chief Marketing Officer, PeriGen
(609) 228-8346
Sandra.Taylor@PeriGen.com

SOURCE PeriGen, Inc.


Source: PR Newswire